References and Notes
1a
Taha TA.
Argraves KM.
Obeid LM.
Biochim. Biophys. Acta: Mol. Cell Biol. Lipids
2004,
1682:
48
1b
Praditpornsilpa K.
Avihingsanon Y.
Transplant Proc.
2004,
36:
1228
1c
Kahan BD.
Transplant Proc.
2004,
36:
S531
1d
Martini S.
Peters H.
Bohler T.
Budde K.
Expert Opin. Investig. Drugs
2007,
16:
505
2a
Fujita T.
Inoue K.
Yamamoto S.
Ikumoto T.
Sasaki S.
Toyama R.
Chiba K.
Hoshino Y.
Okumoto T.
J. Antibiot.
1994,
47:
208
2b
Adachi K.
Kohara T.
Nakao N.
Arita M.
Chiba K.
Mishina T.
Sasaki S.
Fujita T.
Bioorg. Med. Chem. Lett.
1995,
5:
853
2c
Kiuchi M.
Adachi K.
Kohara T.
Minoguchi M.
Hanano T.
Oki Y.
Mishina T.
Arita M.
Nakao N.
Ohtsuki M.
Hoshino Y.
Teshima K.
Chiba K.
Sasaki S.
Fujita T.
J. Med. Chem.
2000,
43:
2946
For previous syntheses of FTY720, see:
3a
Adachi K.
Kohara T.
Nakao N.
Arita M.
Chiba K.
Mishina T.
Sasaki S.
Fujita T.
Bioorg. Med. Chem. Lett.
1995,
5:
853
3b
Kiuchi M.
Adachi K.
Kohara T.
Inoguchi M.
Hanano T.
Aoki Y.
Mishina T.
Arita M.
Nakao N.
Ohtsuki M.
Hoshino Y.
Teshima K.
Chiba K.
Sasaki S.
Fujita T.
J. Med. Chem.
2000,
43:
2946
3c
Durand P.
Peralba P.
Sierra F.
Renaut P.
Synthesis
2000,
505
3d
Kalita B.
Barua NC.
Bezbarua M.
Bez G.
Synlett
2001,
1411
For recent syntheses of FTY720, see:
4a
Kim S.
Lee H.
Lee M.
Lee T.
Synthesis
2006,
753
4b
Sugiyama S.
Arai S.
Kiriyama M.
Ishii K.
Chem. Pharm. Bull.
2005,
53:
100
4c
Seidel G.
Laurich D.
Fürstner A.
J. Org. Chem.
2004,
69:
3950
For FTY720-related compounds, see:
4d
Kiuchi M.
Adachi K.
Tomatsu A.
Chino M.
Takeda S.
Tanaka Y.
Maeda Y.
Sato N.
Mitsutomi N.
Sugahara K.
Chiba K.
Bioorg. Med. Chem.
2005,
13:
425
4e
Hale JJ.
Yan L.
Neway WE.
Hajdu R.
Bergstrom JD.
Milligan JA.
Shei G.-J.
Chrebet GL.
Thornton RA.
Card D.
Rosenbach M.
Rosen H.
Mandala S.
Bioorg. Med. Chem.
2004,
12:
4803
4f
Hale JJ.
Neway W.
Mills SG.
Hajdu R.
Keohane CA.
Rosenbach M.
Milligan J.
Shei G.-J.
Chrebet G.
Bergstrom J.
Card D.
Koo GC.
Koprak SL.
Jackson JJ.
Rosen H.
Mandala S.
Bioorg. Med. Chem. Lett.
2004,
14:
3351
4g
Hinterding K.
Cottens S.
Albert R.
Zecri F.
Buehlmayer P.
Spanka C.
Brinkmann V.
Nussbaumer P.
Ettmayer P.
Hoegenauer K.
Gray N.
Pan S.
Synthesis
2003,
1667
4h
Hinterding K.
Albert R.
Cottens S.
Tetrahedron Lett.
2002,
43:
8095
5
Sivaraman B.
Aidhen IS.
Synlett
2007,
959
N-Methoxy-N-methyl amides are popularly called as Weinreb amides. For reviews on Weinreb amide chemistry, see:
6a
Singh J.
Satyamurthi N.
Aidhen IS.
J. Prakt. Chem.
2000,
342:
340
6b
Mentzel M.
Hoffmann HMR.
J. Prakt. Chem.
1997,
339:
517
6c
Sibi MP.
Org. Prep. Proced. Int.
1993,
25:
15
7
Mickel SJ.
Niederer D.
Daeffler R.
Osmani A.
Kuesters E.
Schmid E.
Schaer K.
Gamboni R.
Chen W.
Loeser E.
Kinder FR.
Konigsberger K.
Prasad K.
Ramsey TM.
Repic O.
Wang R.-M.
Florence G.
Lyothier I.
Paterson I.
Org. Process Res. Dev.
2004,
8:
122
8 Aldehyde 2, a crystalline solid, was conveniently prepared in high overall yield by a literature-known, two-step synthetic procedure, using cheap and commercially available tris(hydroxymethyl)aminomethane (TRIS) as the starting material. See: Ooi H.
Ishibashi N.
Iwabuchi Y.
Ishihara J.
Hatakeyama S.
J. Org. Chem.
2004,
69:
7765
For reviews on Julia olefination, see:
9a
Blakemore PR.
J. Chem. Soc., Perkin Trans. 1
2002,
2563
9b
Kelly SE.
Comp. Org. Synth.
1991,
1:
792
10
4-{(Benzo[
d
]thiazol-2-ylsulfonyl)methyl}-
N
-methoxy-
N
-methylbenzamide (4)
Yield 85-88%; R
f
= 0.35 (hexane-ethyl acetate, 6:4); colorless crystals, mp 142-145 °C. 1H NMR (400 MHz, CDCl3): δ = 3.32 (s, 3 H), 3.47 (s, 3 H), 4.79 (s, 2 H), 7.33 (d, 2 H, J = 8.0 Hz), 7.56-7.62 (m, 3 H), 7.63-7.69 (m, 1 H), 7.94 (d, 1 H, J = 8.0 Hz), 8.26 (d, 1 H, J = 8.0 Hz). 13C NMR (100 MHz, CDCl3): δ = 32.6, 59.7, 60.1, 121.3, 124.6, 126.8, 127.2, 127.8, 127.9, 129.8, 133.9, 136.1, 151.6, 164.1, 168.0. IR (CH2Cl2): 1152, 1332, 1469, 1639, 2929, 2972 cm-1. HRMS (EI): m/z calcd for C17H16N2O4S2 [M + H]+: 377.0630; found: 377.0618.
11a
Tunoori AR.
White JM.
Georg GI.
Org. Lett.
2000,
2:
4091
11b
p-Toluic acid was converted to its acid chloride using more economical SOCl2 and reacted with N-methoxy-N-methyl amine hydrochloride in the presence of 3.0 equiv of Et3N, yield 88-92%.
12
Aïssa C.
J. Org. Chem.
2006,
71:
360
13
General Procedure for Olefination
A suspension of sulfone (0.3 mmol), aldehyde (0.33 mmol, 1.1 equiv), and K2CO3 (0.9 mmol, 3 equiv) in a mixture of THF (1.8 mL) and DMF (0.6 mL; 3:1 mixture) was heated at 70 °C for 17 h. After completion of the reaction, THF was evaporated and the reaction mixture was quenched with H2O and then extracted with EtOAc. The washed organic layer was dried over anhyd Na2SO4, filtered, concentrated, and then purified by silica gel flash chromatography. The spectral and analytical details for selected compounds are given below.
4-[4-(5,5-Dimethyl-1,3-dioxan-2-yl)styryl]-
N
-methoxy-
N
-methylbenzamide (8c)
Yield 64% (E:Z = 3:1). E-Isomer:
R
f
= 0.35 (hexane-EtOAc, 7:3); white crystalline solid, mp 121-124 °C. 1H NMR (400 MHz, CDCl3): δ = 0.73 (s, 3 H), 1.22 (s, 3 H), 3.28 (s, 3 H), 3.48 (s, 3 H), 3.58 (d, 2 H, J = 10.8 Hz), 3.70 (d, 2 H, J = 11.2 Hz), 5.32 (s, 1 H), 7.03 (d, 1 H, J = 16.0 Hz), 7.10 (d, 1 H, J = 16.4 Hz), 7.41-7.46 (m, 6 H), 7.62 (d, 2 H, J = 8.0 Hz). 13C NMR (100 MHz, CDCl3): δ = 20.8, 22.0, 29.2, 32.8, 60.0, 76.7, 100.4, 125.0, 125.6, 127.1, 127.6, 127.8, 129.1, 131.9, 136.5, 137.2, 138.6, 168.5. Z-Isomer:
R
f
= 0.42 (hexane-EtOAc, 7:3); colorless viscous liquid. 1H NMR (400 MHz, CDCl3): δ = 3.27 (s, 3 H), 3.49 (s, 3 H), 3.57 (d, 2 H, J = 10.4 Hz), 3.69 (d, 2 H, J = 11.2 Hz), 5.28 (s, 1 H), 6.51 (d, 1 H, J = 12.4 Hz), 6.57 (d, 1 H, J = 12.4 Hz), 7.17-7.21 (m, 4 H), 7.30 (d, 2 H, J = 8.0 Hz), 7.46 (d, 2 H, J = 8.0 Hz). 13C NMR (100 MHz, CDCl3): δ = 20.9, 22.1, 29.2, 33.0, 59.9, 76.7, 100.6, 125.2, 127.3, 127.5, 127.8, 128.6, 130.2, 131.6, 136.4, 136.6, 138.6, 168.7. IR (CH2Cl2): 1097, 1383, 1417, 1638, 2850, 2954 cm-1. HRMS (EI): m/z calcd for C23H27NO4 [M + H]+: 382.2018; found: 382.2029.
N
-Methoxy-
N
-methyl-4-(2-nitrostyryl)benzamide (8d)
Yield 70% (E:Z = 9:1); R
f
= 0.4 (hexane-EtOAc,7:3); yellow solid, mp 60-63 °C. 1H NMR (400 MHz, CDCl3): δ (E-isomer) = 3.38 (s, 3 H), 3.58 (s, 3 H), 7.09 (d, 1 H, J = 16.0 Hz), 7.42-7.46 (m, 1 H), 7.57 (d, 2 H, J = 8.4 Hz), 7.62 (d, 1 H, J = 7.6 Hz), 7.67 (d, 1 H, J = 16.4 Hz), 7.73 (d, 2 H, J = 8.4 Hz), 7.77 (d, 1 H, J = 7.2 Hz), 7.98-8.00 (m, 1 H); δ (Z-isomer, nonoverlapped signals) = 3.32 (s, 3 H), 3.52 (s, 3 H), 6.77 (d, 1 H, J = 12.0 Hz), 6.97 (d, 1 H, J = 12.0 Hz), 7.49 (d, 2 H, J = 8.0 Hz), 7.81 (d, 1 H, J = 8.0 Hz), 7.93 (d, 1 H, J = 8.0 Hz). 13C NMR (100 MHz, CDCl3): δ (E-isomer) = 33.2, 60.5, 124.4, 124.8, 126.1, 127.8, 127.9, 128.4, 132.2, 132.4, 132.7, 133.3, 138.2, 147.6, 168.8; δ (Z-isomer, nonoverlapped signals) = 60.6, 124.3, 128.2, 130.4, 131.7, 132.8. IR (CH2Cl2): 1264, 1345, 1523, 1635, 3054 cm-1. HRMS (EI): m/z calcd for C17H16N2O4 [M + H]+: 313.1188; found: 313.1194.
4-(3,4-Dimethoxystyryl)-
N
-methoxy-
N
-methyl Benzamide (8e)
Yield 66% (E:Z = 3:1); R
f
= 0.37 (hexane-EtOAc, 7:3); yellow viscous liquid. 1H NMR (400 MHz, CDCl3): δ (E-isomer) = 3.28 (s, 3 H), 3.49 (s, 3 H), 3.82 (s, 3 H), 3.86 (s, 3 H), 6.78 (d, 1 H, J = 8.0 Hz), 6.89 (d, 1 H, J = 16.4 Hz), 6.97-6.99 (m, 2 H), 7.04 (d, 1 H, J = 16.0 Hz), 7.43 (d, 2 H, J = 8.4 Hz), 7.62 (d, 2 H, J = 8.4 Hz); δ (Z-isomer, nonoverlapped signals) = 3.26 (s, 3 H), 3.46 (s, 3 H), 3.54 (s, 3 H), 3.77 (s, 3 H), 6.43 (d, 1 H, J = 12.4 Hz), 6.51 (d, 1 H, J = 12.4 Hz), 6.65-6.68 (m, 2 H), 6.72-6.74 (m, 1 H), 7.24 (d, 2 H, J = 8.4 Hz), 7.47 (d, 2 H, J = 8.4 Hz).
13C NMR (100 MHz, CDCl3): δ = 33.8, 55.8, 55.9, 61.1, 108.8, 111.2, 120.3, 121.9, 125.7, 128.2, 128.5, 128.8, 130.2, 131.2, 132.3, 139.9, 149.1, 149.3, 169.5; δ (Z-isomer non-overlapped signals) = 55.5, 55.8, 60.9, 110.9, 111.7, 125.8, 127.9, 128.6, 129.4, 130.0, 140.2, 148.3, 148.4, 169.6. IR (CH2Cl2): 1264, 1514, 1635, 3053 cm-1. HRMS (EI): m/z calcd for C19H21NO4 [M + H]+: 328.1549; found: 328.1546.
tert
-Butyl {3-[4-Methoxy(methyl)carbamoyl]styryl}-1
H
-indole-1-carboxylate (8f)
Yield 56% (E:Z = 3:2); Rf = 0.27 (hexane-EtOAc, 7:3); pale yellow viscous liquid. 1H NMR (400 MHz, CDCl3): δ (E-isomer) = 1.70 (s, 9 H), 3.38 (s, 3 H), 3.58 (s, 3 H), 7.21 (d, 1 H, J = 17.2 Hz), 7.32-7.38 (m, 4 H), 7.55 (d, 2 H, J = 8.4 Hz), 7.72 (d, 2 H, J = 8.4 Hz), 7.77 (s, 1 H), 7.90 (d, 1 H, J = 7.2 Hz), 8.20 (d, 1 H, J = 8.0 Hz); δ (Z-isomer, nonoverlapped signals) = 3.33 (s, 3 H), 3.52 (s, 3 H), 6.68-6.75 (m, 2 H), 7.08-7.12 (m, 1 H), 7.23-7.29 (m, 2 H), 7.35 (d, 2 H, J = 8.4 Hz), 7.48 (s, 1 H), 7.56 (d, 2 H, J = 8.4 Hz), 8.11 (d, 1 H, J = 8.0 Hz). 13C NMR (100 MHz, CDCl3): δ (E-isomer) = 28.2, 33.8, 61.1, 84.1, 115.5, 118.7, 119.9, 121.7, 123.1, 124.5, 124.8, 125.6, 127.8, 128.5, 128.9, 132.4, 140.1, 149.5, 169.6; δ (Z-isomer, nonoverlapped signals) = 83.8, 115.1, 117.0, 121.5, 122.5, 124.4, 128.3, 129.2, 130.4, 132.6, 135.2. IR (CH2Cl2): 1261, 1457, 1604, 1723, 2853, 2923, 2956 cm-1. HRMS (EI): m/z calcd for C24H26N2O4 [M + H]+: 407.1971; found: 407.1981.
4-[2-(Furan-2-yl)vinyl]-
N
-methoxy-
N
-methyl Benzamide (
8g)
Yield 75% (E:Z = 5:4); Rf = 0.3 (hexane-EtOAc, 7:3); yellow viscous liquid. 1H NMR (400 MHz, CDCl3): δ (E-isomer) = 3.26 (s, 3 H), 3.46 (s, 3 H), 6.18-6.23 (m, 1 H), 6.29-6.37 (m, 4 H), 6.85 (d, 1 H, J = 16.0 Hz), 6.94 (d, 1 H, J = 16.4 Hz), 7.37-7.41 (m, 4 H), 7.56-7.60 (m, 3 H); δ (Z-isomer, nonoverlapped signals) = 3.27 (s, 3 H), 3.48 (s, 3 H). 13C NMR (100 MHz, CDCl3): δ (E-isomer) = 33.8, 61.0, 109.5, 111.8, 118.0, 125.7, 126.0, 128.8, 132.6, 139.4, 142.5, 152.9, 169.5; δ (Z-isomer, nonoverlapped signals) = 110.7, 111.3, 118.9, 126.7, 128.1, 128.3, 139.8, 141.9, 151.7, 169.7. IR (CH2Cl2): 1378, 1416, 1639, 2929 cm-1. HRMS (EI): m/z calcd for C15H15NO3 [M + H]+: 258.1130; found: 258.1138.
14
(
E
)-
tert
-Butyl (5-{4-[Methoxy(methyl)carbamoyl]sty-ryl}-2,2-dimethyl-1,3-dioxan-5-yl)carbamate (9)
Yield 70%; R
f
= 0.35 (hexane-EtOAc, 6:4); colorless solid, mp 115-118 °C. 1H NMR (400 MHz, CDCl3): δ = 1.36 (s, 9 H), 1.38 (s, 3 H), 1.40 (s, 3 H), 3.26 (s, 3 H), 3.45 (s, 3 H), 3.82-3.92 (m, 4 H), 5.27 (br s, 1 H), 6.23 (d, 1 H, J = 16.4 Hz), 6.48 (d, 1 H, J = 16.4 Hz), 7.30 (d, 2 H, J = 8.0 Hz), 7.56 (d, 2 H, J = 8.4 Hz). 13C NMR (100 MHz, CDCl3): δ = 19.6, 27.4, 28.3, 33.7, 53.0, 60.9, 66.0, 79.6, 98.3, 125.9, 128.6, 129.5, 130.0, 132.9, 138.8, 154.8, 169.4. IR (CHCl3): 1166, 1456, 1637, 1712, 2851, 2921 cm-1. HRMS (EI): m/z calcd for C22H33N2O6 [M + H]+): 421.2339; found: 421.2348.
15
General Procedure for the Addition of Grignard Reagent, R
¹
MgBr to the Weinreb Amides 9 and 14
To a stirred solution of 9 or 14 (0.7 mmol) in anhyd THF (3 mL), the appropriate solution of alkyl or arylmagnesium bromide (4.2 mmol, 6 equiv) in anhyd THF (5 mL) was added under inert atmosphere at -10 °C and the mixture was stirred for 3 h between -10 °C and 0 °C. Subsequent hydrolysis was achieved by cautious addition of sat. NH4Cl solution. The aqueous layer was extracted with EtOAc, dried over Na2SO4, and concentrated to furnish the crude product, which was purified by silica gel column chromatography using hexane-EtOAc (85:15) to afford ketones 10a-e and 15, respectively. The spectral and analytical details for selected compounds are given below.
(
E
)-
t
e
rt
-Butyl [5-(4-Heptanoylstyryl)-2,2-dimethyl-1,3-dioxan-5-yl]carbamate (10b)
Yield 65%; R
f
= 0.4 (hexane-EtOAc, 7:3); colorless solid, mp 86-89 °C. 1H NMR (400 MHz, CDCl3): δ = 0.89 (t, 3 H, J = 7.2 Hz), 1.29-1.35 (m, 6 H), 1.44 (s, 9 H), 1.48 (s, 3 H), 1.49 (s, 3 H), 1.68-1.74 (m, 2 H), 2.94 (t, 2 H, J = 7.6 Hz), 3.91-4.01 (m, 4 H), 5.27 (br s, 1 H), 6.35 (d, 1 H, J = 16.4 Hz), 6.58 (d, 1 H, J = 16.4 Hz), 7.43 (d, 2 H, J = 8.0 Hz), 7.90 (d, 2 H, J = 8.0 Hz). 13C NMR (100 MHz, CDCl3): δ = 14.0, 19.4, 22.5, 24.3, 27.7, 28.4, 29.0, 31.9, 38.6, 53.1, 66.1, 79.8, 98.4, 126.5, 128.5, 129.5, 131.0, 136.1, 140.9, 154.8, 200.0. IR (CHCl3): 1167, 1466, 1601, 1682, 1716, 2853, 2923 cm-1. HRMS (EI): m/z calcd for C26H40NO5 [M + H]+: 446.2906; found: 446.2899.
(
E
)-
tert
-Butyl [2,2-Dimethyl-5-(4-octanoylstyryl)-1,3-dioxan-5-yl]carbamate (10d)
Yield 75%; R
f
= 0.4 (hexane-EtOAc, 7:3); colorless solid, mp 83-86 °C. 1H NMR (400 MHz, CDCl3): δ = 0.88 (t, 3 H, J = 7.2 Hz), 1.28-1.38 (m, 8 H), 1.44 (s, 9 H), 1.47 (s, 3 H), 1.49 (s, 3 H), 1.70-1.74 (m, 2 H), 2.93 (t, 2 H, J = 7.2 Hz), 3.91-4.00 (m, 4 H), 5.25 (br s, 1 H), 6.35 (d, 1 H, J = 16.4 Hz), 6.58 (d, 1 H, J = 16.4 Hz), 7.43 (d, 2 H, J = 8.4 Hz), 7.90 (d, 2 H, J = 8.0 Hz). 13C NMR (100 MHz, CDCl3): δ = 14.0, 19.5, 22.6, 24.5, 27.6, 28.4, 29.0, 29.3, 32.8, 38.6, 53.1, 66.1, 79.8, 98.4, 126.5, 128.4, 129.5, 131.0, 136.1, 140.9, 154.8, 199.9. IR (CHCl3): 1168, 1456, 1603, 1685, 1719, 2853, 2923 cm-1. HRMS (EI): m/z calcd for C27H42NO5 [M + H]+: 460.3063; found: 460.3076.
(
E
)-
tert
-Butyl [5-(4-Benzoylstyryl)-2,2-dimethyl-1,3-dioxan-5-yl]carbamate (10e)
Yield 72%; R
f
= 0.4 (hexane-EtOAc, 7:3); colorless solid, mp 109-112 °C. 1H NMR (400 MHz, CDCl3): δ = 1.45 (s, 9 H), 1.48 (s, 3 H), 1.50 (s, 3 H), 3.92-4.01 (m, 4 H), 5.24 (br s, 1 H), 6.37 (d, 1 H, J = 16.4 Hz), 6.61 (d, 1 H, J = 16.4 Hz), 7.45-7.50 (m, 4 H), 7.57-7.59 (m, 1 H), 7.76-7.79 (m, 4 H). 13C NMR (100 MHz, CDCl3): δ = 19.5, 27.7, 28.4, 53.1, 66.1, 79.8, 98.4, 126.2, 128.2, 129.5, 129.9, 130.0, 132.3, 136.5, 137.7, 140.6, 154.8, 196.1. IR (CHCl3): 1165, 1494, 1601, 1655, 1711, 2927, 2976 cm-1. HRMS (EI): m/z calcd for C26H32NO5 [M + H]+: 438.2280; found: 438.2281.
16a
Fürstner A.
Leitner A.
Méndez M.
Krause H.
J. Am. Chem. Soc.
2002,
124:
13856
16b
Fürstner A.
Leitner A.
Angew. Chem. Int. Ed.
2002,
41:
609
16c See also ref. 4c and references cited therein.
Reagents and conditions:
17a PPh3 (1.2 equiv), acetone, reflux, 6 h, 80%;
17b P(OEt)3 (1.5 equiv), toluene, 110 °C, 8 h, 60%.
{4-[Methoxy(methyl)carbamoyl]benzyl}(triphenyl)phos-phonium Bromide (12)
Yield 80%; R
f
= 0.2 (MeOH-CHCl3, 3:7); white solid. 1H NMR (400 MHz, CDCl3): δ = 3.32 (s, 3 H), 3.57 (s, 3 H), 5.06 (d, 2 H, J
HP = 15.2 Hz), 7.12 (d, 2 H, J = 8.0 Hz), 7.49 (d, 2 H, J = 8.0 Hz), 7.69-7.76 (m, 12 H), 7.90-7.94 (m, 3 H). 13C NMR (100 MHz, CDCl3): δ = 30.3, 30.8, 61.7, 118.5, 119.4, 129.6, 131.5, 131.8, 131.9, 132.0, 135.3, 135.5, 135.7, 136.6, 170.7. IR (CHCl3): 1165, 1368, 1645, 3026 cm-1.
Diethyl {4-[Methoxy(methyl)carbamoyl]benzyl}phos-phonate (13)
Yield 60%; R
f
= 0.1 (hexane-EtOAc, 3:7), colorless liquid. 1H NMR (400 MHz, CDCl3): δ = 1.25 (t, 6 H, J = 6.8 Hz), 3.18 (d, 2 H, J
HP = 22.0 Hz), 3.35 (s, 3 H), 3.55 (s, 3 H), 4.00-4.06 (m, 4 H), 7.34 (dd, 2 H, J = 2.4, 8.0 Hz), 7.65 (d, 2 H, J = 8.0 Hz). 13C NMR (100 MHz, CDCl3): δ = 16.3, 33.6 (d, J
CP = 140 Hz), 33.7, 60.9, 62.2, 128.5, 129.4, 132.5, 134.5, 169.5. IR (CHCl3): 1019, 1220, 1380, 1633, 2981 cm-1. HRMS (EI): m/z calcd for C14H23NO5P [M + H]+: 316.1314; found: 316.1317.
18
tert
-Butyl (5-{4-[Methoxy(methyl)carbamoyl]styryl}2,2-dimethyl-1,3-dioxan-5-yl)carbamate (9 +
Z
-isomer)
Yield 70% (Z:E = 3:1); R
f
= 0.35 (hexane-EtOAc, 6:4); colorless liquid. 1H NMR (400 MHz, CDCl3): δ (Z-isomer) = 1.32 (s, 3 H), 1.38 (s, 9 H), 1.45 (s, 3 H), 3.37 (s, 3 H), 3.56 (s, 3 H), 3.77 (d, 2 H, J = 11.6 Hz), 3.88-3.94 (m, 2 H), 5.20 (br s, 1 H), 5.65 (d, 1 H, J = 12.8 Hz), 6.68 (d, 1 H, J = 12.8 Hz), 7.30 (d, 2 H, J = 8.0 Hz), 7.64 (d, 2 H, J = 8.0 Hz); δ (E-isomer, nonoverlapped signals) = 3.35 (s, 3 H), 3.53 (s, 3 H), 3.88-3.94 (m, 4 H), 5.27 (br s, 1 H), 6.23 (d, 1 H, J = 16.4 Hz), 6.48 (d, 1 H, J = 16.4 Hz), 7.39 (d, 2 H, J = 8.0 Hz). 13C NMR (100 MHz, CDCl3): δ (Z-isomer) = 18.8, 19.4, 20.9, 27.6, 28.3, 33.7, 52.5, 60.9, 65.8, 79.4, 98.1, 125.9, 128.6, 129.5, 130.0, 132.9, 140.1, 154.4, 169.4; δ (E-isomer, nonoverlapped signals) = 53.0, 66.0, 98.3, 127.9, 131.5, 132.6, 138.8. IR (CHCl3): 1166, 1456, 1637, 1712, 2851, 2921 cm-1. HRMS (EI): m/z calcd for C22H33N2O6 [M + H]+: 421.2339; found: 421.2348.
19
tert
-Butyl (5-{4-[Methoxy(methyl)carbamoyl]pheneth-yl}-2,2-dimethyl-1,3-diox-an-5-yl)carbamate (14)
Yield 95%; R
f
= 0.35 (hexane-EtOAc, 6:4); colorless solid, mp 89-91 °C. 1H NMR (400 MHz, CDCl3): δ = 1.42 (s, 3 H), 1.44 (s, 3 H), 1.48 (s, 9 H), 1.98-2.02 (m, 2 H), 2.58-2.62 (m, 2 H), 3.35 (s, 3 H), 3.55 (s, 3 H), 3.69 (d, 2 H, J = 12.0 Hz), 3.90 (d, 2 H, J = 12.0 Hz), 5.01 (br s, 1 H), 7.21 (d, 2 H, J = 8.0 Hz), 7.60 (d, 2 H, J = 8.0 Hz). 13C NMR (100 MHz, CDCl3): δ = 18.9, 27.4, 28.3, 28.6, 32.3, 32.8, 50.6, 59.9, 65.2, 78.4, 97.4 126.1, 126.9, 127.5, 130.6, 143.9, 153.9, 168.8. IR (CHCl3): 1164, 1453, 1638, 1710, 2934, 2976 cm-1. HRMS (EI): m/z calcd for C22H35N2O6 [M + H]+: 423.2495; found: 423.2486.
20
tert
-Butyl [2,2-Dimethyl-5-(4-octanoylphenethyl)-1,3-dioxan-5-yl]carbamate (15)
Yield 70%; R
f
= 0.4 (hexane-EtOAc, 7:3); colorless solid, mp 60-63 °C. 1H NMR (400 MHz, CDCl3): δ = 0.88 (t, 3 H, J = 6.8 Hz), 1.25-1.35 (m, 8 H), 1.42 (s, 3 H), 1.44 (s, 3 H), 1.47 (s, 9 H), 1.70-1.74 (m, 2 H), 1.99-2.11 (m, 2 H), 2.60-2.64 (m, 2 H), 2.92 (t, 2 H, J = 7.2 Hz), 3.69 (d, 2 H, J = 12.0 Hz), 3.89 (d, 2 H, J = 12.0 Hz), 4.95 (br s, 1 H), 7.26 (d, 2 H, J = 8.0 Hz), 7.87 (d, 2 H, J = 8.0 Hz). 13C NMR (100 MHz, CDCl3): δ = 13.2, 19.0, 21.7, 23.7, 26.3, 27.6, 28.2, 28.5, 28.8, 30.8, 32.4, 37.7, 50.9, 65.5, 78.8, 97.6, 127.5, 127.7, 134.4, 146.7, 154.1, 199.3. IR (CHCl3): 1198, 1498, 1606, 1682, 1715, 2856, 2926 cm-1. HRMS (EI): m/z calcd for C27H44NO5 [M + H]+: 462.3219; found: 462.3229.